Tags: Cancer | breast cancer drug | palbociclib | letrozole

New Breast Cancer Drug Improves Survival

Monday, 03 February 2014 12:23 PM


 
Pfizer Inc said its experimental breast cancer drug, in a mid-stage trial, showed a statistically significant improvement in patients' survival rates without their disease worsening.
The drug palbociclib was tested in post-menopausal patients in combination with the hormonal therapy letrozole, and results were compared with patients receiving only letrozole.

© 2021 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Health-News
Pfizer Inc said its experimental breast cancer drug, in a mid-stage trial, showed a statistically significant improvement in patients' survival rates without their disease worsening.The drug palbociclib was tested in post-menopausal patients in combination with the hormonal...
breast cancer drug,palbociclib,letrozole
49
2014-23-03
Monday, 03 February 2014 12:23 PM
Newsmax Media, Inc.
 
Newsmax TV Live

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved